Serina Therapeutics, Inc. (SER): debt financing — AgeX draws $500K under secured convertible note with Juvenescence; due Feb 14, 2024

Serina Therapeutics, Inc.

Drew $500,000 of credit available under Amended and Restated Secured Convertible Promissory Note with Juvenescence Limited.
Repayment date for outstanding principal is February 14, 2024.
Material terms previously reported in 10-Q and 8-K filings from May, June, and August 2023.

item 2.03 item 1.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Serina Therapeutics, Inc. incurred loan of $500,000 with Juvenescence Limited maturing February 14, 2024.

Instrument: loan
Principal: $500,000
Counterparty: Juvenescence Limited
Maturity: February 14, 2024
Event: incurrence

Exact text from the filing

On September 11, 2023, AgeX drew $500,000 of its credit available under the Amended and Restated Secured Convertible Promissory Note

View on SEC.gov

89 debt financings filed in the last 30 days. Browse all debt financings →

Serina Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-032759

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.